Legend Biotech Corporation (LEGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Legend Biotech Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -13.50x | -33.61x | -20.44x | -17.79x | -16.27x | -12.49x |
| P/B Ratio | 4.00x | 5.72x | 8.47x | 10.67x | 8.57x | 5.57x |
| P/S Ratio | 3.89x | 9.49x | 37.16x | 67.86x | 95.39x | 44.36x |
| Profitability | ||||||
| Gross Margin | 60.3% | 62.6% | 49.4% | 44.1% | 100.0% | 100.0% |
| Operating Margin | -13.3% | -48.3% | -154.1% | -389.4% | -570.0% | 0.0% |
| Net Margin | -28.8% | -28.2% | -181.8% | -381.5% | -586.4% | -355.2% |
| EBITDA Margin | -22.6% | -18.0% | -167.6% | -356.0% | -570.1% | -397.5% |
| Liquidity | ||||||
| Current Ratio | 1.96x | 4.62x | 6.92x | 3.69x | 4.14x | 5.14x |
| Quick Ratio | 1.91x | 4.54x | 6.83x | 3.66x | 4.14x | 5.12x |
| Leverage | ||||||
| Debt/Equity | 0.41x | 0.34x | 0.26x | 0.38x | 0.16x | 0.01x |
YoY = year-over-year change. Source: FMP..